Led · Debt Financing · Aug 2026

HealthSnap offers an enterprise-grade, EMR-integrated virtual care management platform that combines RPM, CCM, PCM, APCM, AI-augmented clinical workflows, enterprise analytics, reimbursement optimization, and care coordination. The company has embedded AI across care delivery to produce clinician-facing recommendations within clinician-defined protocols and safety guardrails, and launched an AI-augmented APCM solution earlier in the year. HealthSnap supports more than 80,000 active patient programs across 200 health systems and physician organizations, and projects more than 100,000 active patient programs by the end of 2026. Its platform ingests roughly two patient measurements every second, and patients see a 97% reduction in alert frequency by their twelfth month. The company reported significant commercial momentum and financial improvement, including more than fivefold revenue growth over three years, 40% year-over-year revenue growth, and a 47% year-over-year improvement in EBITDA. HealthSnap’s clinical research has shown measurable outcomes, including an average 7.3 mmHg reduction in systolic blood pressure across a cohort of more than 6,500 patients (rising to 16.7 mmHg for Stage 2 hypertensive patients) and retrospective findings of material reductions in total cost of care, hospitalizations, and ED visits among high-acuity Medicare beneficiaries.

Participated · Debt Financing · Aug 2023

Flueid builds a VOT™ (Verification of Title) product suite that uncovers title condition and associated risks at the start of residential real estate transactions. Its offerings include an upfront TitleCheck® verification and the title underwriter‑approved Flueid Decision platform, which aim to expedite title search and examination and automate title insurance underwriting. The tools are used by title agents, underwriters, mortgage lenders, servicers, and real estate professionals to improve transparency and reduce transaction complexity and timelines. The company says its technology has gained strong momentum in the title industry and is widely accepted by top insurers. Flueid plans to scale its VOT solutions across the real estate lifecycle and use new capital to accelerate product development, business growth, and go‑to‑market initiatives. The company positions VOT as a standard verification service to foster greater integration between mortgage originators and title providers. Flueid develops the Flueid Decision platform to deliver Verification of Title (VOT) solutions that integrate title data and intelligence into workflows across the real estate life cycle. Since launching in 2020, the company has scaled the platform and added decisioning capabilities for loss mitigation, loan modification, refinance, home equity and purchase. It has integrated the platform with two point-of-sale and loan origination systems to enable mortgage lenders and credit unions to conduct title checks at loan origination. Flueid emphasizes title underwriter-approved logic, rule sets, robust data sets and industry best practices to support lenders, servicers, title agents, underwriters, fintechs and platform providers. The company plans to use the Series B1 funding to add integrations, refine its purchase solution, and introduce default and capital markets offerings to round out its VOT suite. Headquartered in Austin, Texas, Flueid positions VOT as a new category to bring title intelligence upstream and streamline transactions. Flueid’s core product, Flueid Decision, is a title-data-driven platform built on a security-first architecture that embeds data and insights into POS, LOS, TPS, servicing platforms and marketplaces. The platform is adopted by multiple Fortune 500 companies, including top lenders, brokerages, marketplaces, title agents, underwriters and servicing platforms to power workflow decisions. As of summer 2022 Flueid supported more than one million transactions; in 2021 the company reported a 400% increase in revenue and an 800% increase in monthly transaction volume. The company has expanded beyond refinance capabilities to add purchase and home equity transactions and plans to mature and scale products to support home equity and loss mitigation strategies. Flueid has achieved SOC 2 Type I and Type II certifications, was awarded its first patent and a continuation patent, and acquired next‑gen real estate software provider Vodii. Management describes the company’s mission as making the real estate process more fluid and delivering a seamless consumer experience across market cycles. Flueid Software Corporation, based in Austin, Texas, is a fast-growing insurtech that provides real estate closing automation solutions to the title insurance, real estate, and mortgage lending industries. Its products use data and automation to eliminate inefficiencies and automate backend title processing and closing functions. Flueid recently released a solution for mortgage lenders and servicers that delivers an underwriter-backed title clearance decision and turn-time estimates, accelerating loan pipeline management. The company works with major title insurance, real estate, and mortgage lending partners and emphasizes enterprise-wide automation to increase productivity and reduce redundancy. Flueid plans to use the investment to continue technology development, support current product implementations, and penetrate additional markets through sales and marketing expansion.

Led · Equity · Jan 2023

Mad Mobile builds digital and mobile experiences and payment solutions for restaurant and retail customers, offering a suite that includes mobile POS, mobile ordering, self-checkout, clienteling, mobile fulfillment, and contactless payment. The company serves more than 21,000 major restaurant and retail locations globally and processes roughly $3B in payments annually. Its CAKE point-of-sale solution was acquired from Sysco Corporation in 2020. Mad Mobile’s customers include Ralph Lauren, Tractor Supply, Texas Roadhouse, Talbots, Signet Jewelers, Urban Outfitters and others. Led by CEO Bruce Bennett, the company plans to amplify expansion of its SaaS and payment technologies and accelerate sales growth. The company also intends to use new funds to refinance existing debts. Mad Mobile provides a connected commerce platform and mobile payments solutions that create modern point-of-sale transactions for retailers and restaurants. Led by CEO Bruce Bennett, the company builds digital and mobile experiences for more than 21,000 retail and restaurant locations. Customers include Ralph Lauren, Tractor Supply, Meijer, Texas Roadhouse, Talbots, Aramark, Estee Lauder, Signet Jewelers and others. The company said it will use the $20M in new funding to accelerate development of its technology platform for modern point-of-sale and payments and to drive commercial market growth. Mad Mobile is based in Tampa, FL. Mad Mobile provides Concierge, a mobile application and cloud-based platform that gives store associates mobile access to product and customer information and tools to deliver a personalized shopping experience. The platform surfaces real-time data from enterprise systems to enable customer journeys such as Clienteling, BOPIS, Endless Aisle, and MPOS. The company completed a seven-figure, revenue-based financing transaction with Decathlon Capital Partners; the precise amount was not disclosed. Mad Mobile intends to use the funds to expand the reach of its Concierge solution. The company is led by CEO Bruce Bennett and has had Concierge deployed by major retailers including Talbots, Helzberg Diamonds, Books-A-Million, Ashley Furniture, Timberland, The North Face, and Vans.

Led · Debt Financing · Mar 2021

Augmedix delivers AI-powered ambient medical documentation and data solutions that convert natural clinician–patient conversations into medical notes clinicians can review, finalize, and transfer in real time to the electronic health record. Its technology targets both ambulatory care and, through a new collaboration, the acute care setting. The company plans to work with HCA Healthcare to advance AI-powered ambient documentation products for acute care clinicians and to accelerate development of products such as Augmedix Go. Augmedix raised approximately $12 million in new equity from HCA Healthcare and Redmile Group via a combination of new common shares and pre-funded warrants priced at $1.60 per share. The financing also included issuance of conditional “break even” warrants tied to specific future financing events. Management says the new capital, together with existing cash and availability under an existing debt facility, should enable the company to reach cash flow sustainability and avoid additional equity raises, with breakeven expected as it exits 2024. The company and Redmile have also agreed to finalize within 30 days an equity line option of up to $5 million at $1.60 per share that could be accessed 12–18 months after finalization, although management does not anticipate using it. Augmedix provides remote medical documentation and live clinical support, converting natural clinician–patient conversation into medical documentation using proprietary automation modules and human-expert assistants operating in HIPAA-secure locations. Its platform supports over 35 specialties and is used by more than one dozen American health systems and hundreds of independent clinicians across medical offices, clinics, hospitals and telemedicine. The company estimates its solution saves clinicians 2–3 hours per day, can increase productivity by as much as 20%, and improves clinicians' satisfaction with work-life balance by over 40%. Augmedix completed a fourth quarter 2020 capital raise and achieved an OTCQX listing, and management cites strong financial performance. In March 2021 the company refinanced its long-term debt to enhance the balance sheet and significantly extend operating runway. Proceeds from the refinancing were used to pay down existing long-term debt and for working capital and general corporate purposes. Augmedix offers a platform that converts natural clinician–patient conversation into medical documentation and delivers live clinical support such as referrals, orders, and reminders. Its platform combines proprietary automation modules with human-expert assistants operating in HIPAA-secure locations to produce accurate, comprehensive, and timely documentation. Augmedix says its services are compatible with over 35 specialties and are trusted by more than one dozen U.S. health systems across telemedicine, clinics, and hospitals. The company estimates its solution saves clinicians 2–3 hours per day, can increase productivity by as much as 20%, and improve certain clinicians' work‑life balance by 49%. Management said the COVID‑19 pandemic has accelerated telemedicine adoption and highlighted Augmedix’s competitive advantages. The company plans to broaden operational capabilities, accelerate technology research and product development, and strengthen marketing and sales following the financing. Augmedix provides real‑time medical documentation by turning natural clinician–patient conversation into notes via a platform powered by proprietary natural‑language‑processing technology and medical documentation expert teams. The company supplies clinicians with hardware (Smartphones or Google Glass) to securely stream visits to its cloud‑based platform, where tech‑enabled remote specialists and proprietary automation modules generate comprehensive documentation. Its service covers more than 25 specialties and supports most EHRs. Fifteen national health systems, including Sutter Health, CommonSpirit Health, and US Oncology, representing over 10% of clinicians in the U.S., have partnered with Augmedix. The company is led by CEO Manny Krakaris. It raised an additional $19M in Series B financing to accelerate product development, including automation capabilities, and to scale its technology‑enabled service across health systems and private clinics nationwide. Augmedix offers a Google Glass-powered remote scribe service that lets physicians retrieve patient history and document visits without interacting with a computer; chart notes are created in real time by remote scribes in secure HIPAA-compliant facilities. The service enables physicians to review notes and provide patients with visit summaries and care instructions. Augmedix complements its core offering with enterprise support services including staffing, quality assurance, network and technical support, analytics and business process improvement. The company has received more than $60 million in venture funding since founding. It intends to use the new funds to further scale its service nationwide and build out its platform with new tools and services.

Participated · Equity · Dec 2019

PrecisionHawk provides drone hardware, software, and services to enterprise customers, with a core software product called PrecisionAnalytics that applies AI/ML to aerial data. PrecisionAnalytics helps enterprises turn drone-collected data into actionable insights for asset management and operational decision-making. The company serves Fortune 500 clients across agriculture, energy, and telecommunications, including five of the top 10 utility companies, the largest U.S. communications infrastructure provider, and the Big Six seed and agricultural chemical firms. Common use cases include asset inventory, inspecting telecommunications towers and electricity distribution lines, and measuring crop health. PrecisionHawk says it will use new financing to continue innovating its software, accelerate sales initiatives, and expand into additional markets, positioning the business for sustained profitability and growth. Founded in 2010 and headquartered in Raleigh, N.C., the company has been active in policy and technology development for commercial drone adoption, and CEO Michael Chasen serves as Chairman of the FAA's Drone Advisory Committee. To date PrecisionHawk has raised more than $130 million from venture and strategic investors. PrecisionHawk provides drone technology and software to help enterprises integrate drone data into their business insight capture processes. The company serves Fortune 500 companies and market leaders in 150 countries across industries including agriculture, energy, insurance, government and construction. Led by CEO Michael Chasen, PrecisionHawk was founded in 2010 and is headquartered in Raleigh, NC. The company has raised more than $100M in total funding to date. PrecisionHawk will use the new capital to expand its team, focus on product innovation and pursue strategic acquisitions. The article does not disclose revenue or user metrics. PrecisionHawk began as a maker of Lancaster fixed-wing drones for farmers and has shifted focus to a cloud platform for aerial data services. Its DataMapper service lets users upload, store, manage and analyze drone-gathered data; a freemium tier exists and a premium “platinum” account costs $95/month for up to 750 GB. The company is developing LATAS (Low Altitude Traffic and Airspace Safety) to help drone operators get clearance, track and verify flights and report paths to the FAA. PrecisionHawk is testing LATAS with partners including the U.S. FAA, NASA and private companies such as Verizon, DigitalGlobe and Harris. With a recent $18M Series C, the company plans to expand beyond agriculture into oil & gas, mining, insurance, search and rescue, forestry and telecommunications. CEO Bob Young says the fastest-growing part of the business is the aerial data services platform rather than selling aircraft. PrecisionHawk builds drones outfitted with sensors and cameras and provides analytics and reporting tools for land surveys. The company offers about a dozen sensor options that customers can select or add themselves, and it collects and stores survey data for subsequent analysis. Customers are notified when survey reports are ready, and PrecisionHawk plans to launch a DataMapper dashboard to let users work with, manipulate, share and run algorithms on their survey data. The company intends to use new funding to expand operations and double its team. PrecisionHawk is also working to expand into new use cases including oil and gas and emergency response.